| Ms Sandra Barrett, MD | |
|
7550 West Village Circle, Suite 1, Wichita, KS 67205 | |
| (316) 838-2020 | |
| (316) 838-7574 |
| Full Name | Ms Sandra Barrett |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 7550 West Village Circle, Wichita, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952381568 | NPI | - | NPPES |
| 200261940A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 04-30670 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sandra Barrett, MD 7550 West Village Circle, Suite 1, Wichita, KS 67205 Ph: (316) 838-2020 | Ms Sandra Barrett, MD 7550 West Village Circle, Suite 1, Wichita, KS 67205 Ph: (316) 838-2020 |
News Archive
Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.
Researchers identified several structurally disparate compounds that can inhibit the viral protease PLpro and determined whether the identified PLpro inhibitors are truly effective and should be further investigated.
TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing. The financing was led by Bio*One Capital, a subsidiary of Singapore based EDB Investments with strong support from current investors, Three Arch Partners and Adams Street Partners.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Using advanced imaging techniques and cognitive tests, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center , the University Hospital and academic medical center for Einstein, have shown that repeatedly heading a soccer ball increases the risk for brain injury and cognitive impairment.
› Verified 6 days ago
Brianne Michelle Hobson, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1725 E Douglas Ave Ste 103, Wichita, KS 67211 Phone: 316-202-0987 Fax: 316-202-0988 | |
Amanda L Roy, CPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2067 N. West St., Wichita, KS 67203 Phone: 316-942-5335 Fax: 316-942-5442 | |
Dr. Jude Cook, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8338 W 13th St N, Wichita, KS 67212 Phone: 316-729-8888 | |
Robbie O'brien-leighton, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1947 Founders Circle, Wichita, KS 67206 Phone: 316-613-4756 Fax: 316-613-4726 | |
John K Hoerner, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1151 N Rock Rd, Wichita, KS 67206 Phone: 316-634-3400 Fax: 316-634-3434 | |
Sarah Ohm, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1262 N Pine Grove Ct, Wichita, KS 67212 Phone: 316-734-2441 | |
Blake C Veenis, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3515 W Central Ave, Wichita, KS 67203 Phone: 316-755-0144 Fax: 844-274-1204 |